PRIMARY OBJECTIVE:~1. To evaluate change in participant informed decision-making after provision of a consultation audio recording application.~SECONDARY OBJECTIVES:~Reach. To evaluate the percentage of invited participants who enroll. Reasons for not enrolling will be assessed.~Adoption. To evaluate the percentage of providers who agree to be recorded.~Adoption. To evaluate the percentage of participants who create an audio recording.~Adoption. To evaluate the percentage of participants who listen to the audio recording or read its automatically generated transcript.~Implementation. To evaluate the percentage of participants who report receiving instructions on how to record.~To evaluate participant-reported shared decision-making effort.~To evaluate whether participant-reported anxiety changes after provision of a consultation audio recording app.~To evaluate barriers, facilitators, and experiences of recording app use, particularly in the context of treatment decision-making by conducting participant interviews, provider surveys, and interviews with providers.~Treatment received.~EXPLORATORY OBJECTIVES:~To evaluate whether provision of a consultation audio recording app improves participant-reported knowledge retention of docetaxel.~To evaluate accuracy of app auto-generated transcription.~To evaluate degree of provider decision support and communication skills.~Participants are set up with an application prior to the first physician visit and then followed-up 7 days, 28 days and 60 days after their physician encounter.
This is a single-arm hybrid implementation trial of men with metastatic castrate-resistant prostate cancer (mCRPC) involving a patient-administered mobile app for consultation audio recordings.